These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37324107)

  • 1. Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway.
    Zhai K; Jiang N; Wen JF; Zhang X; Liu T; Long KJ; Ke XX; Xu G; Chen C
    J Thorac Dis; 2023 May; 15(5):2644-2658. PubMed ID: 37324107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
    Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWF1 induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the cAMP signaling pathway.
    Wang Y; Zuo R; Huo G; Han Z; He Y; Luo Y; Chen L; Li G; Cui J; Zhu F; Yue P; Yuan D; Sun Y; Li Z; Chen P; Guo H
    FASEB J; 2023 Jul; 37(7):e23051. PubMed ID: 37358822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors.
    Huo G; Wang Y; Chen J; Song Y; Zhang C; Guo H; Zuo R; Zhu F; Cui J; Chen W; Chen W; Chen P
    Front Oncol; 2021; 11():692136. PubMed ID: 34113576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNPNAT1 Serves as a Prognostic Biomarker Correlated with Immune Infiltration and Promotes Cancer Cell Metastasis through Stabilization of Snai2 in Lung Adenocarcinoma.
    He J; Li F; Jing Z; Ren X; Jia D; Zeng Y; Yu Y
    Biomedicines; 2024 Jul; 12(7):. PubMed ID: 39062049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma.
    Qi N; Niu Y; Li Z; Xiao L; Tang D; Gao W
    Transl Cancer Res; 2022 Oct; 11(10):3471-3490. PubMed ID: 36388055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases.
    Chen C; Guo Q; Tang Y; Qu W; Zuo J; Ke X; Song Y
    J Thorac Dis; 2021 Aug; 13(8):5016-5034. PubMed ID: 34527340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
    Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
    Front Oncol; 2022; 12():921200. PubMed ID: 35774125
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Jiang F; Huang X; Yang X; Zhou H; Wang Y
    Front Oncol; 2022; 12():795971. PubMed ID: 35814368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma.
    Shi K; Li QY; Zhang YQ; Huang H; Ding DX; Luo WM; Zhang J; Guo Q
    Aging (Albany NY); 2023 Oct; 15(20):11067-11091. PubMed ID: 37899135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CENPH overexpression promotes the progression, cisplatin resistance, and poor prognosis of lung adenocarcinoma via the AKT and ERK/P38 pathways.
    Li Q; Huang X; Li QY; Tang Y; Liang LB; Luo Q; Gong M; Song YX; Guo Q; Chen C
    Am J Cancer Res; 2023; 13(5):1682-1697. PubMed ID: 37293159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma.
    Zhang H; Yan X; Gu H; Xue Q; Liu X
    J Thorac Dis; 2022 Dec; 14(12):4785-4802. PubMed ID: 36647484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
    Tang X; Zhou H; Liu Y
    Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of glycolysis-related
    Yu H; Yu Z; Qin C; Bian T; Shi M
    J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma.
    Kang J; Abudurufu M; Zhang S; Jiang W; Luo H
    J Cancer; 2023; 14(8):1417-1426. PubMed ID: 37283796
    [No Abstract]   [Full Text] [Related]  

  • 16. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2.
    Wu CY; Liu Z; Luo WM; Huang H; Jiang N; Du ZP; Wang FM; Han X; Ye GC; Guo Q; Chen JL
    Heliyon; 2024 Jun; 10(12):e32025. PubMed ID: 38952374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
    Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
    Front Oncol; 2022; 12():862564. PubMed ID: 35600383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
    Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
    Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.